Chemopreventive agents such as selective estrogen receptor modulators (tamoxifen and raloxifene) and aromatase inhibitors (exemestane and anastrozole) have been shown to reduce breast cancer risk by 41%-79% among high-risk women [6]. The gene discussed is CYP19A1; the disease is breast cancer.